Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 278-488-1 | Lisinopril | 76547-98-3 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Eye Irrit. 2 | H319 | H319 |
GHS07 GHS08 Wng |
State/Form
|
2 | View details | |||||
| Repr. 2 | H361 (H361d: Suspecte...) | H361 | |||||||||
| Skin Irrit. 2 | H315 | H315 |
GHS07 GHS08 Dgr |
State/Form
|
1 | View details | |||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| Repr. 1A | H360 | H360 | |||||||||
| Lact. | H362 | H362 | |||||||||
| STOT RE 2 | H373 (other:Kidney, R...) | H373 | |||||||||
| STOT RE 2 | H373 (Kidney, Respira...) | H373 | |||||||||
| Eye Irrit. 2 | H319 | H319 |
GHS07 GHS08 Dgr |
State/Form
|
1 | View details | |||||
| Repr. 1A | H360 (D) | H360 (D) | |||||||||
| Lact. | H362 | H362 | |||||||||
| Not Classified | 1 | ||||||||||
| Skin Irrit. 2 | H315 | H315 |
GHS07 GHS08 Dgr |
State/Form
|
1 | View details | |||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| Repr. 1A | H360 | H360 | |||||||||
| Repr. 1A | H360 (oral) | H360 | |||||||||
| STOT RE 2 | H373 (other:Niere) | H373 | |||||||||
| STOT RE 2 | H373 (Niere) | H373 | |||||||||
Number of Aggregated Notifications: 5